상세 보기
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia
- Fujishima, Naohito;
- Uchida, Toshiki;
- Onishi, Yasushi;
- Jung, Chul Won;
- Goh, Yeow Tee;
- 외 9명
WEB OF SCIENCE
8SCOPUS
13초록
Inotuzumab ozogamicin (InO) is a targeted treatment for adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). InO was previously studied in INO-VATE, an international, open-label, randomized phase 3 trial comparing InO against standard of care (SoC). In the present subgroup analysis, we evaluated outcomes in the 55 Asian patients who were randomized in INO-VATE (31 InO and 24 SoC). Complete remission (CR) or CR with incomplete hematologic recovery (CRi) was achieved in 22/31 patients treated with InO versus 5/24 treated with SoC. In the InO arm, more of the patients achieving CR/CRi were minimal residual disease (MRD)-negative (17/22 versus 1/5), and more patients proceeded directly to hematopoietic stem cell transplantation (15/31 versus 3/24). Median overall survival for the respective arms was 5.8 versus 3.9 months (hazard ratio 0.67; 97.5% CI 0.28, 1.62). In the safety analysis (n = 51), the most common adverse events were hematologic. Sinusoidal obstruction syndrome was reported in five InO patients and one SoC patient. In conclusion, Asian patients with relapsed or refractory B-cell ALL experienced improved efficacy with InO versus SoC, with an efficacy and safety profile consistent with results of the overall INO-VATE population.
키워드
- 제목
- Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia
- 저자
- Fujishima, Naohito; Uchida, Toshiki; Onishi, Yasushi; Jung, Chul Won; Goh, Yeow Tee; Ando, Kiyoshi; Wang, Ming Chung; Ono, Chiho; Matsumizu, Miyako; Paccagnella, M. Luisa; Sleight, Barbara; Vandendries, Erik; Fujii, Yosuke; Hino, Masayuki
- 발행일
- 2019-12
- 유형
- Article
- 권
- 110
- 호
- 6
- 페이지
- 709 ~ 722
- 언어
- ENG
- 출판사
- Japanese Society of Hematology
- 발행국가
- 일본
- 분량
- 14 페이지
- ISSN
- E 1865-3774
P 0925-5710